stars 1 stars 2 stars 3

Nerbio is revolutionizing in-hospital patient monitoring by integrating intelligent, FDA-cleared devices with the power of mobile technology. Our flagship product, iTOF®, is the world’s first and only FDA-cleared, wireless, app-controlled quantitative train-of-four (TOF) monitor. Designed for use with smartphones and tablets, iTOF delivers precise, real-time neuromuscular assessments—without the need for bulky standalone equipment or large capital investment. Now enhanced with advanced AI assistance, iTOF enables clinicians to more accurately guide the dosing of neuromuscular blocking agents and determine optimal timing for post-operative recovery—improving safety, efficiency, and outcomes in perioperative care. Nerbio is building a comprehensive platform of mobile, AI-powered monitoring solutions—advancing our vision of smarter, more connected, and more effective care for clinicians and hospitals worldwide.

Nerbio Questions

Ken Leonard is the Co-Founder, Chief Innovation Officer, Member BOD of Nerbio.

7 people are employed at Nerbio.

Nerbio is based in San Jose, California.

Top Nerbio Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users